New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Editas Medicine, Inc. (EDIT) vs Eikon Therapeutics, Inc. (EIKN)
- Editas Medicine, Inc. EDIT 1.64 −4.09%
- Eikon Therapeutics, Inc. EIKN 4.74 −0.42%
Editas Medicine, Inc. and Eikon Therapeutics, Inc. are both Biotechnology companies. Editas Medicine, Inc. and Eikon Therapeutics, Inc. are of similar size ($263.9M and $257.9M). Across the 8 metrics below, Editas Medicine, Inc. leads on 5 and Eikon Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | EDIT | EIKN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (151.71%) | — | 0.00% |
| Net margin | (144.95%) | — | 0.00% |
| Free cash flow margin | (221.15%) | — | 0.00% |
| Return on equity | (147.44%) | 359.35% | (51.58%) |
| Return on assets | (34.30%) | (56.31%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack